STOCKHOLM, Sweden, Oct. 17, 2005 (PRIMEZONE) -- Industrivarden has sold a total of 75,000,000 shares (corresponding to 19.48% of the votes and capital) in the Icelandic medical technology company Ossur hf for approximately SEK 837 M.
Industrivarden's remaining holding thereafter amounts to 14,817,286 shares, corresponding to 3.85% of the votes and capital.
The sale gives rise to a capital gain of approximately SEK 327 M for Industrivarden. The surplus value of the remaining holding amounts to SEK 73 M.
Commenting on the sale of the shares, Industrivarden's CEO Anders Nyren said: "We took a position as an active owner of Ossur in 2002, and through close involvement we have participated in the company's strong expansion. Industrivarden were the first international investor to recognize the excellent investment potential of Ossur. Our investment excluding the participation in the new issue of SEK 155 M in September/October grew in value by approximately 90%. The sale is a good move for us and generated a substantial capital gain."
Stockholm, October 17, 2005
AB INDUSTRIVARDEN (publ)
For further information, please contact: Anders Nyren, President and CEO, tel. +46-8-666 64 00
This information was brought to you by Waymaker.
The following files are available for download:http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=141332&fn=wkr0001.pdf
-0-